Figures & data
Table 1. Summary of included papers, quality assessment, and key details related to vaccine delay
Table 2. Number of papers by WHO region
Table 3. Number of included papers by country of study
Figure 3. Number of papers assessing the timeliness of different antigens as primary or secondary outcome measures (n = 67)
![Figure 3. Number of papers assessing the timeliness of different antigens as primary or secondary outcome measures (n = 67)](/cms/asset/956acafe-dcbe-4afe-afcb-62dafebd7047/khvi_a_1616503_f0003_oc.jpg)
Figure 4. Number of papers reporting different variables used as predictors of vaccine timeliness in multivariable regression (n = 67)
![Figure 4. Number of papers reporting different variables used as predictors of vaccine timeliness in multivariable regression (n = 67)](/cms/asset/3e45d8de-4a07-40a5-9efa-c8ce53f77c3b/khvi_a_1616503_f0004_b.gif)